Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule Labeling

[Image: see text] The new readily available prosthetic group, tetrafluorophenyl 4-fluoro-3-iodobenzoate (TFIB), designed for both molecular imaging and targeted radionuclide therapy purposes was radiolabeled either with fluorine or iodine radionuclides with excellent radiochemical yields and puritie...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ACS Med Chem Lett
Autors principals: Billaud, Emilie M. F., Vidal, Aurélien, Vincenot, Amélie, Besse, Sophie, Bouchon, Bernadette, Debiton, Eric, Miot-Noirault, Elisabeth, Miladi, Imen, Rbah-Vidal, Latifa, Auzeloux, Philippe, Chezal, Jean-Michel
Format: Artigo
Idioma:Inglês
Publicat: American Chemical Society 2014
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329574/
https://ncbi.nlm.nih.gov/pubmed/25699145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml500423v
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars